Parkinson's Disease Trial, Recruiting NCT06490809 Sponsor: Emre Şenocak Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06490809
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with Parkinson's disease at a mild to moderate stage (rated between 1 and 3 on a standard Parkinson's scale called the Hoehn & Yahr scale)
  • People who are in their "On" phase, meaning a period when their Parkinson's medication is working and symptoms are better controlled
  • People who have not received any physiotherapy treatment before their first assessment for this trial

Who may not be able to join:

  • People who score below 24 points on a standard memory and thinking test (suggest confirming the specific test used with the trial site)
  • People who have severe involuntary movements (uncontrolled muscle movements caused by Parkinson's medication)
  • People whose symptoms fluctuate significantly between better periods ("On") and worse periods ("Off")
  • People who have had a type of brain surgery for Parkinson's disease called stereotaxic surgery
  • People whose Parkinson's medication dose has been changed in the last three months
  • People with an unstable heart or lung condition
  • People who have an arm or shoulder problem, or have had surgery that affects how well their arms and hands work

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Murat Emirzeoğlu, PhD, Karadeniz Technical University

Phone: +90 553 569 56 92

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Emre Şenocak
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 January 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Box and Block Test; Box and Block Test; Global Rating of Patient-Perceived Changes (GRP-PC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov